The Goldman Sachs Group, Inc. 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-24 9:00 pm Sale |
2024-06-13 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
GOLDMAN SACHS GROUP INC GS |
1,285,188 3.500% |
-1,380,494 (-51.79%) |
Filing |
| 2024-06-21 4:52 pm Purchase |
2024-06-11 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
GOLDMAN SACHS GROUP INC GS |
2,665,682 7.500% |
2,665,682 (New Position) |
Filing |